CYTOMX THERAPEUTICS I
1,0000
07-ноября-24 15:59:50
15 мин. задержка
Акции
0,0000
0,00%
Сегодняшний диапазон
0,9882 - 1,0800
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
17 ноя 2022 07:00:00 Источник Nasdaq GlobeNewswire
-
CytomX Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
08 ноя 2022 16:10:00 Источник Nasdaq GlobeNewswire
-
07 ноя 2022 16:15:00 Источник Nasdaq GlobeNewswire
-
CytomX Therapeutics to Present at Upcoming November Investor Conferences
02 ноя 2022 16:15:01 Источник Nasdaq GlobeNewswire
-
CytomX Therapeutics to Report Third Quarter 2022 Financial Results on November 8, 2022
01 ноя 2022 08:00:01 Источник Nasdaq GlobeNewswire
-
CytomX Therapeutics Announces Phase 1 Data Update for anti-CTLA-4 Probody® Therapeutic BMS-986249
12 сен 2022 08:00:02 Источник Nasdaq GlobeNewswire
-
07 сен 2022 18:05:00 Источник Nasdaq GlobeNewswire
-
CytomX Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update
04 авг 2022 16:15:00 Источник Nasdaq GlobeNewswire
-
CytomX Therapeutics to Present at Upcoming Virtual August Investor Conferences
03 авг 2022 08:00:02 Источник Nasdaq GlobeNewswire
-
CytomX Therapeutics to Report Second Quarter 2022 Financial Results on August 4, 2022
28 июл 2022 08:00:01 Источник Nasdaq GlobeNewswire
-
CytomX Therapeutics Provides Strategic Update
13 июл 2022 16:05:00 Источник Nasdaq GlobeNewswire
-
CytomX Therapeutics Announces Phase 2 Results for Praluzatamab Ravtansine in Breast Cancer
06 июл 2022 16:05:00 Источник Nasdaq GlobeNewswire
-
CytomX Therapeutics Announces New Employment Inducement Grants
16 июн 2022 08:00:01 Источник Nasdaq GlobeNewswire
-
CytomX Therapeutics to Present at Jefferies 2022 Global Healthcare Conference
01 июн 2022 08:00:01 Источник Nasdaq GlobeNewswire
-
26 май 2022 08:00:00 Источник Nasdaq GlobeNewswire
-
CytomX Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update
05 май 2022 16:15:00 Источник Nasdaq GlobeNewswire
-
CytomX Therapeutics to Report First Quarter 2022 Financial Results on May 5, 2022
28 апр 2022 08:00:02 Источник Nasdaq GlobeNewswire
-
CytomX Therapeutics Announces Retirement of John A. Scarlett, M.D. from Board of Directors
14 апр 2022 16:15:00 Источник Nasdaq GlobeNewswire
-
CytomX Therapeutics Announces Retirement of Frederick W. Gluck from Board of Directors
23 мар 2022 16:15:00 Источник Nasdaq GlobeNewswire
-
17 мар 2022 08:00:01 Источник Nasdaq GlobeNewswire